Supplements for ADHD in Children: What Parents Should Know

5 min read ·
Bottom Line

Supplements have a limited but real role in childhood ADHD, and none of them rival stimulant medication. The best-studied is omega-3 (especially higher-EPA formulas): a meta-analysis of 10 trials in 699 children found a small but genuine reduction in symptoms, well below the effect of methylphenidate or amphetamines. Correcting a confirmed iron or zinc deficiency can also help — zinc lowered the needed amphetamine dose in one trial — but iron should never be given without ferritin testing because excess is toxic, and magnesium/B6 evidence stays weak. The practical takeaway is that supplements are an adjunct, not a replacement for proper assessment, and any plan should run through the child’s pediatrician.

Omega-3 Fatty Acids (EPA/DHA)

This is the most studied supplement category in pediatric ADHD. Children with ADHD often have lower blood levels of EPA and DHA compared with neurotypical children. The Bloch & Qawasmi 2011 meta-analysis in the Journal of the American Academy of Child and Adolescent Psychiatry pooled 10 RCTs of 699 children and found a small but significant effect on ADHD symptoms; supplements with higher EPA content produced larger effects. Effect sizes were modest compared with stimulant medications such as methylphenidate or amphetamines. Trial doses ranged from roughly 500–1,000 mg/day combined EPA+DHA.

Iron, Zinc, and Magnesium

Iron deficiency (even without anemia) is associated with ADHD severity — low ferritin correlates with worse symptom scores. The Konofal et al. 2008 pilot RCT in Pediatric Neurology randomized 23 nonanemic children with ferritin under 30 ng/mL to ferrous sulfate 80 mg/day or placebo for 12 weeks, with significant decreases on the ADHD Rating Scale in the iron group. The trial is small and was 3:1 randomized, so it should be considered hypothesis-supporting rather than confirmatory. Iron should not be supplemented without confirmed deficiency via ferritin testing, as excess iron is toxic.

Zinc is a cofactor for dopamine synthesis. The Arnold et al. 2011 placebo-controlled trial of 52 children in Journal of Child and Adolescent Psychopharmacology tested zinc 15 mg once daily or 15 mg twice daily; clinical end points were equivocal but objective neuropsychological measures favoured the twice-daily dose, and twice-daily zinc lowered the optimal amphetamine dose by 37%. Combined magnesium and vitamin B6 supplementation has been studied in small trials with inconsistent results; evidence remains preliminary.

Important Caveat

No supplement studied to date approaches the efficacy of evidence-based ADHD treatments (stimulant or non-stimulant medication, behavioral therapy). Supplements should not replace proven treatments. Discuss any supplementation with your pediatrician, especially iron, which requires testing before use.

Sources

  1. Bloch MH, Qawasmi A. "Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis." Journal of the American Academy of Child and Adolescent Psychiatry, 2011;50(10):991–1000. PMID 21961774. DOI: 10.1016/j.jaac.2011.06.008.
  2. Konofal E, Lecendreux M, Deron J, et al. "Effects of iron supplementation on attention deficit hyperactivity disorder in children." Pediatric Neurology, 2008;38(1):20–26. PMID 18054688. DOI: 10.1016/j.pediatrneurol.2007.08.014.
  3. Arnold LE, Disilvestro RA, Bozzolo D, et al. "Zinc for attention-deficit/hyperactivity disorder: placebo-controlled double-blind pilot trial alone and combined with amphetamine." Journal of Child and Adolescent Psychopharmacology, 2011;21(1):1–19. PMID 21309695. DOI: 10.1089/cap.2010.0073.
  4. Cortese S, Ferrin M, Brandeis D, et al. (European ADHD Guidelines Group). "Cognitive training for attention-deficit/hyperactivity disorder: meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials." Journal of the American Academy of Child and Adolescent Psychiatry, 2015;54(3):164–174. DOI: 10.1016/j.jaac.2014.12.010.

Reviewed against 4 peer-reviewed sources.